DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

Repligen Corp (NASDAQ: RGEN)

24.29 -0.67 (-2.68%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RGEN $24.29 -2.68%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $21.45
Previous Close $24.96
Daily Range $21.45 - $24.81
52-Week Range $12.04 - $26.75
Market Cap $794.8M
P/E Ratio 69.33
Dividend (Yield) $0.00 (0.0%)
Volume 375,005
Average Daily Volume 365,142
Current FY EPS $0.30

Sector

Healthcare

Industry

Drugs

Repligen Corp (RGEN) Description

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system. Website: http://www.repligen.com/

News & Commentary Rss Feed

3 Stocks to Get on Your Watchlist

A biopharmaceutical company with an upcoming FDA decision, a discount store attracting possible buyout interest, and a potentially overvalued life sciences company are this week's three must-watch stocks.

Repligen (RGEN) Shares March Higher, Can It Continue? - Tale of the Tape

Repligen (RGEN) Shares March Higher, Can It Continue? - Tale of the Tape

RGEN Crosses Below Key Moving Average Level

Repligen's (RGEN) CEO Walter Herlihy on Q3 2014 Results - Earnings Call Transcript

Repligen (RGEN) Q3 2014 Results - Earnings Call Webcast

Amgen And Regeneron Reach All-Time Highs Together: Updates On Both Biotech Stalwarts

Regeneron Genetics Center Fully Operational, Announces New Collaborations And Key Appointments

Commit To Buy Repligen At $20, Earn 20.4% Annualized Using Options

Nike Jumps On Strong Results; Powell Industries Shares Slide

Nike Jumps On Strong Results; Powell Industries Shares Slide

3 Big-Volume Health Care Stocks in Breakout Territory

See More RGEN News...

RGEN's Top Competitors

RGEN $24.29 (-2.68%)
Current stock: RGEN
AMGN $152.26 (-2.63%)
Current stock: AMGN
GILD $104.83 (0.62%)
Current stock: GILD
BIIB $389.16 (10.17%)
Current stock: BIIB